Johnson & Johnson, hygiene products and giant pharmaceuticals, sank this Friday 10.4% In Wall Street, what became Large percentages have fallen by more than a decade. All of that has been published after Reuters in pharmacy I found out that powdered baby powder had asbestos.
J & J has made 6,000 cases, in the case of baby shower and shower products that cause obesity cancer.
The decrease in shares did not change $ 24 million worth of the company and its shares became the biggest trace in the Dow Jones and S & P 500 indexes.
According to Reuters, J & J has been aware of small amounts of asbestos since 1971, as in many of the internal pharmaceutical company reports and pharmaceutical documents as in other confidential documents.
J & J has been aware of small amounts of asbestos since 1971
The report also showed that the company commissioned and commissioned the study on Baby Powder franchise Ghostwriter hired to rewrite the article presented by the magazine's findings.
The company says that it is history "Absurd conspiracy theory"J & J has used all the methods used by independent regulators and experts that J & J Talca has asbestos and all of these methods are our cosmetic talc because they are asbestos."
The failure of Johnson and Johnson's millions of words is not sold in Argentina
J & J has faced 10,000 cases, which cause children's pox and shower shower for ovarian cancer. The products have also been linked mesotheliomaA strange and deadly type of cancer that causes the delicate tissue of the body cavity.
A few months ago, the United States's highest health authority (FDA) Asbestos's presence did not analyze the sample of the product. However, the jury of Saint Louis, Missouri did not allow $ 4.96 million to be paid in July, due to the fact that 22 women and their families had been ill because of the baby's product. The company made a ruling.
Last year, a Los Angeles court In addition, the multinational accused 417 million dollars for women to develop obario cancer After using Urumerik powder. According to the Convention, Johnson & Johnson did not warn about the risk of cancer of product use. The decision was successful in the company. "Science was established," said Bart Williams, a giant pharmacy lawyer. On Wall Street, Friday, skepticism for investors was dominant.
Source: La Vanguardia and El País